Lorena Tonarelli MSc

Medical Writer, Copywriter, Journalist



A senior consultant in market access/HEOR and medical communications, Lorena has more than 15 years of professional freelance experience in medical writing and editing. She works with medical communications agencies, market access/HEOR consultancies, and pharmaceutical and medical device companies on a wide range of products, therapy areas and drug classes. Lorena is a member of the European Medical Writers Association (EMWA).  She has a degree of Master of Science in Science and a bachelor's degree (Hons) in Natural Sciences, as well as research laboratory experience.


Global value/reimbursement dossiers • Key value message development and testing • Value stories and propositions • Core value slide decks • Payer/KOL discussion guides and interviewing • Critical assessments of treatment, regulatory, payer and competitor landscapes • Advisory board/KOL meeting reports • Abstracts and posters for presentation at conferences • Manuscripts for publication in medical journals • Slide decks • Infographics • Workshops • Symposium reviews • Clinical summaries • Publication summaries • Reference packs • Objection handlers • Project proposals • Quality control (QC) • Educational content •

Therapy areas

Oncology (multiple myeloma, leukaemia, lymphoma, and brain, breast, ovarian, lung, kidney, pancreatic, prostate
and skin cancers) • Cardiovascular (stroke, myocardial infarction, cardiac arrest, heart failure, arrhythmias) •
Neurology (Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy) • Diabetes and complications
(nephropathy, retinopathy) • ADHD • Psoriasis • Atopic dermatitis • Cystic fibrosis • Immunodeficiency diseases •
Asthma • COPD • Rheumatology • Ophthalmology (AMD, glaucoma, diabetic retinopathy, retinoblastoma)

Drug classes

Anti PD-1/PD-L1 and CTLA-4 mAbs • LADD-based immunotherapies • PARP inhibitors • Tyrosine kinase inhibitors (VEGFR TKIs, HER2 TKIs) • CDK4/6 inhibitors • EGFR/cMet bispecific antibodies • Immunomodulatory agents • PCSK9 inhibitors • SGLT2 inhibitors • DAPT • Factor Xa inhibitors • Angiotensin receptor-neprilysin inhibitors •
Aldosterone synthase inhibitors • Guanylyl cyclase activators • CX3CR1-binding agents • Recombinant human GLP-2 analogues • Anti-TNF monoclonal antibodies • IL-23 inhibitors • IL-4/IL13 signalling inhibitor • LAMAs/LABAs • CFTR potentiators • Immunoglobulins


In-depth understanding of clinical trials and the pharmaceutical product’s life cycle • Interprets and presents, as text and graphically, clinical as well as budget impact (BI) and cost-effectiveness (CE) data • Familiar with PubMed searches,  reference mark-up, and EndNote use • Supports end clients throughout projects, by applying expert therapy area and product knowledge, attending meetings, addressing amendment requests, and ensuring objectives are met • Reviews the work of others, including medical writers, KOLs and researchers


Prime Global • The Lucid Group • Envision Pharma Group • PAREXEL International Corporation • Bedrock Healthcare Communications • RJW & Partners • E-vate • Porterhouse Medical Group • The European Medical Journal (EMJ) • Celgene Corporation • Novartis Oncology • Medtronic • DDB Remedy • Hayward Medical Comms • Johnson & Johnson • Merck Serono • Pfizer UK • Chandler Chicco Agency • Freiberg Press Inc. • Bupa UK • Curated Digital • Insight-2-Implement • General Electric (GE) Healthcare

Print Print | Sitemap
© 2019 Lorena Tonarelli, M.Sc. B.Sc. (Hons)